Scope
The IAP practice chapter describes a clinical approach to cow’s milk protein allergy in infants and children: distinguish immediate and delayed reactions, avoid diagnostic overreach, confirm the diagnosis safely and protect growth. It emphasises hypoallergenic feeding options, emergency planning and specialist involvement for severe disease or oral immunotherapy.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Distinguish milk allergy from other explanations
- Distinguish cow’s milk protein allergy from lactose intolerance: allergy is immune-mediated, and simultaneous skin, respiratory or systemic symptoms should raise suspicion beyond an isolated gastrointestinal intolerance. [1]
- Use the timing and pattern of reactions to distinguish immediate IgE-mediated symptoms from delayed non-IgE disease. Immediate reactions can involve several systems and carry an anaphylaxis risk; delayed disease is predominantly gastrointestinal. [1]
- Suspect food protein-induced enterocolitis syndrome when recurrent vomiting, pallor and lethargy develop 2–4 hours after milk ingestion. This pattern warrants attention rather than being labelled simple milk intolerance. [1]
- Avoid both missed diagnosis and overdiagnosis: the chapter links missed allergy to nutritional and growth problems, and overdiagnosis to unnecessary formula changes, anxiety and cost. [1]
Confirm the clinical pattern and plan challenge safely
- For suspected IgE-mediated allergy, use skin-prick testing or serum specific IgE in the clinical context. Positive tests indicate sensitisation and require corroboration from the history; component-resolved testing is reserved for selected situations under an allergist. [1]
- For non-IgE disease, use strict milk elimination for 2–4 weeks followed by controlled reintroduction. Improvement during elimination makes the diagnosis likely, while the setting for reintroduction depends on severity. [1]
- The chapter identifies oral food challenge under qualified allergy supervision as the diagnostic reference standard, including when diagnosis is unclear or tolerance is being assessed. Avoid challenge after recent anaphylaxis or with uncontrolled asthma. [1]
Preserve nutrition while avoiding the relevant protein
- Encourage continued breastfeeding, with expert guidance for severe symptoms or poor growth rather than an automatic switch away from breast milk. Detailed maternal dietary and supplementation regimens require individual guidance. [1]
- For formula-fed infants with mild-to-moderate allergy, the stated choice is an extensively hydrolysed formula. For severe allergy, anaphylaxis, FPIES or failure to thrive, the table recommends an amino-acid formula. [1]
- The chapter advises against soy formula before 6 months and against its use in IgE-mediated milk allergy. It also notes that some milk-allergic children react to soy. [1]
- Do not substitute goat, camel, buffalo or sheep milk because of cross-reactivity. The chapter also advises against nut-based milk as an infant substitute because of poor nutritional adequacy. [1]
Plan reactions and reassess nutritional progress
- For severe reactions or anaphylaxis, give intramuscular adrenaline and arrange emergency referral. Patients with prior anaphylaxis should receive an adrenaline prescription; the chapter mentions autoinjector or locally available alternatives. [1]
- Monitor growth and nutritional adequacy regularly, and reassess for tolerance every 6–12 months. Reintroduction through a challenge or structured milk ladder requires the stated qualified-allergist supervision. [1]
- Refer for moderate-to-severe IgE symptoms, uncertain diagnosis, suspected FPIES or enteropathy, severe proctocolitis, poor growth, persistent gastrointestinal symptoms or multiple food allergies. Need for challenge, immunotherapy or endoscopy also supports referral. [1]
Keep immunotherapy within specialist care
- Consider milk oral immunotherapy only through an experienced allergist and centre, for confirmed persistent IgE-mediated allergy with significant accidental-exposure risk and an adherent, motivated family. [1]
- Explain that oral immunotherapy is intended to reduce the risk of anaphylaxis after accidental exposure and is not a cure. [1]
- Avoid oral immunotherapy where the clinician lacks experience, or with severe uncontrolled asthma, active or previous eosinophilic oesophagitis, poor adherence or uncontrolled atopic dermatitis. [1]
Limitations and use
- Full diagnostic and feeding algorithms are not reproduced; this summary focuses on the narrative assessment, feeding and referral recommendations.
- The source does not supply a complete anaphylaxis protocol, milk-ladder schedule or oral immunotherapy dosing regimen.
- Maternal dietary restrictions and calcium or vitamin D supplementation require individual guidance; a universal maternal regimen is not provided.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Cow's Milk Protein Allergy
Selected recommendation material consulted
Publication details
- Issuing organisation
- IAP
- Resource type
- Practice guideline · House clinical summary
- Source setting
- India
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.